Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial (Q42948960)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 August 2010
edit
Language Label Description Also known as
English
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial
scientific article published on 2 August 2010

    Statements

    Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial (English)
    Sue E Ashley
    Jacqueline Oates
    Andrea Turner
    Janine Webb
    Claire Saffery
    Yu Jo Chua
    Ian Chau
    2 August 2010
    3945-3950

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit